Drug Facts

Active Ingredients (in each dose)	Purpose
Brilliant green 2.29 mg	Prevent Infection
Proflavine hemisulfate 1.14 mg	Prevent Infection
Gentian violet 2.29 mg	Prevent Infection

Use

aids in the prevention of infection in the umbilical cord area of newborn

Contraindications

none

Warnings

for external use only.

Keep out of reach of children.

Directions

Peel paper portion of package down over base of ampule.
Avoid touching tip during removal.
With tip in downward position, pinch center to crush ampule.
Apply to area to be prepped using accepted technique.
Discard as non-hazardous waste.

Other information

store at controlled room temperature 15° - 30° C (58° - 86° F)

Inactive ingredients

aqueous solution

PRINCIPAL DISPLAY PANEL - 100 Swab Box

VistaPharm®

100 TRIPLE DYE DISPOS•A•SWABS

UMBILICAL AREA ANTISEPTIC

Each Dispos-A-Swab contains
0.65ml. Each ml contains brilliant
green 2.29mg, gentian violet
2.29mg, proflavine hemisulfate
1.14mg, in an aqueous solution.

KERR TRIPLE DYE

PACKAGED BY: VistaPharm, Inc., Largo, FL 33771, USA

KERR 100 TRIPLE DYE DISPOS-A
proflavine hemisulfate, brilliant green, and gentian violet swab

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:66689-710
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
PROFLAVINE HEMISULFATE (UNII: 27V8M747VB) (PROFLAVINE - UNII:CY3RNB3K4T)	PROFLAVINE HEMISULFATE	1.14 mg in 1 mL
BRILLIANT GREEN (UNII: G0L543D370) (BRILLIANT GREEN CATION - UNII:S85JD8CLBH)	BRILLIANT GREEN	2.29 mg in 1 mL
GENTIAN VIOLET (UNII: J4Z741D6O5) (GENTIAN VIOLET CATION - UNII:3GVJ31T6YY)	GENTIAN VIOLET	2.2 mg in 1 mL

Ingredient Name	Strength
Inactive Ingredients
WATER (UNII: 059QF0KO0R)

Product Characteristics
Color	green (Violet)	Score
Shape		Size
Flavor		Imprint Code
Contains

#	Item Code	Package Description	Marketing Start Date
Packaging
1	NDC:66689-710-06	100 in 1 BOX	05/01/2004
1		1 mL in 1 APPLICATOR; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC Monograph Drug	505G(a)(3)	05/01/2004

Labeler - VistaPharm, LLC (116743084)